Generation Bio Co expected to post a loss of 61  cents a share - Earnings Preview

Generation Bio

06/05/2022 15:17

* Generation Bio Co  GBIO.OQ   GBIO.O  is expected to show a
rise
in quarterly revenue when it reports  results 
    * The Cambridge Massachusetts-based  company is expected to
report
revenue of $1.5 million, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Generation Bio Co
is for
a loss of 61 cents per share. For the same quarter last year,
the company reported a loss of 55 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Generation
Bio Co
is $25​, above​ its last closing price of $6.44. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.53       -0.52                        
 Dec. 31 2022  -0.58       -0.57      -0.54     Beat    5.3
 Sep. 30 2021  -0.56       -0.56      -0.56     Met     -0.6​
 Jun. 30 2021  -0.47       -0.47      -0.55     Missed  -17.7
 ​​Mar.        -0.45       -0.45      -0.46     Missed  -2.2
 31 2021                                                
 Dec. 31 2020  -0.48       -0.50      -0.27     Beat    46.4​
 Sep. 30 2020  -0.46       -0.45      -0.46     Missed  -1.7
 Jun. 30 2020  -0.60       -0.60      -1.50     Missed  -149
 This summary was machine generated May 6 at 14:17 GMT.  All
figures in US dollars  unless otherwise stated